Enough Is Enough: The Pandemic and Loss of Female Oncologists Enough Is Enough: The Pandemic and Loss of Female Oncologists
The Great Resignation is having a profound effect on oncology as new doctors are losing their mentors and role models.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news

Spanish-Speaking Navigators Aid Latinx Patients in CRC Screening Spanish-Speaking Navigators Aid Latinx Patients in CRC Screening
An outreach effort in Rhode Island boosted rates of colonoscopy well above the national benchmark.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2022 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

FDA Approves First Drug for Cold Agglutinin Disease FDA Approves First Drug for Cold Agglutinin Disease
Sutimlimab-jome is the first drug to have FDA approval for the treatment cold agglutinin disease, a rare autoimmune hemolytic anemia in which antibodies destroy red blood cells.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Primer Message Boosts Colorectal Cancer Screening Rates Primer Message Boosts Colorectal Cancer Screening Rates
Sending adults an electronic notification prior to mailing a fecal immunochemical test improves rates of test completion.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Oncologists in Malpractice Suits: Less Than Other Specialties Oncologists in Malpractice Suits: Less Than Other Specialties
Compared to physicians across all specialities, oncologists were less likely to be sued in 2021, which may be due to a decline in oncology-related care during the pandemicMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Closing the Care Gap' Campaign Launched on World Cancer Day'Closing the Care Gap' Campaign Launched on World Cancer Day
The new 3-year campaign focuses on"addressing the barriers that prevent people around the world from accessing the cancer care they need."Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Poor Sleep Increases Esophageal Cancer Risk Poor Sleep Increases Esophageal Cancer Risk
Several sleep behaviors were associated with greater esophageal cancer risk. The study was published on medrxiv.org as a preprint and has not yet been peer reviewedFirst Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Possible Increased Risk of Death With Lymphoma Drug: FDA Possible Increased Risk of Death With Lymphoma Drug: FDA
The FDA has issued a drug safety communication about umbralisib after initial results from a phase 3 trial suggested an elevated mortality risk in patients receiving the oral agent.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Home-Based Physical Activity Helps Reduce Cancer Fatigue Home-Based Physical Activity Helps Reduce Cancer Fatigue
Offering home-based physical activity interventions alongside frequent counseling could help to reduce fatigue in cancer survivors, concludes a meta-analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 2, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Yescarta Label Updated: Prophylactic Steroids to Prevent CRS Yescarta Label Updated: Prophylactic Steroids to Prevent CRS
However, labeling notes a potential increase in neurologic toxicity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 2, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EMA Gives Green Light to New CAR-T Cell Therapy EMA Gives Green Light to New CAR-T Cell Therapy
The European body has recommended approval of a new CAR-T cell therapy, as well as two generic version of dasatinib and a biosimilar of pegfilgrastim.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

ACS/ASCO Websites Are Cross-Posting Patient Info ACS/ASCO Websites Are Cross-Posting Patient Info
In a new collaboration, the American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) are cross-posting information for patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Vitamin D Shows No Survival Benefit in Nondeficient Elderly Vitamin D Shows No Survival Benefit in Nondeficient Elderly
Monthly supplementation with vitamin D showed no improvements in mortality outcomes in a population of elderly Australians who were not deficient.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2022 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Preventing Febrile Neutropenia Recurrence in Gynecologic Cancer Preventing Febrile Neutropenia Recurrence in Gynecologic Cancer
New research suggests that high-dose G-CSF can prevent recurrence in women undergoing chemotherapy. The study was published on researchsquare.com as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Surrogate Endpoints Acceptable in AML Trials, Says FDA Surrogate Endpoints Acceptable in AML Trials, Says FDA
In the case of drugs used for newly diagnosed acute myeloid leukemia (AML), surrogate endpoints have been validated, says the US Food and Drug Administration.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news